Murat YILMAZ
(Bolu Abant İzzet Baysal Üniversitesi, Tıp Fakültesi, Nöroloji Anabilim Dalı, Bolu, Türkiye)
Ayşen Tuğba CANBAŞOĞLU YILMAZ
(Bolu Özel Çağsu Hastanesi, Nöroloji Anabilim Dalı, Bolu, Türkiye)
Handan TEKER
(Bolu Abant İzzet Baysal Üniversitesi, Tıp Fakültesi, Nöroloji Anabilim Dalı, Bolu, Türkiye)
Şule AYDIN TÜRKOĞLU
(Bolu Abant İzzet Baysal Üniversitesi, Tıp Fakültesi, Nöroloji Anabilim Dalı, Bolu, Türkiye)
SERPİL YILDIZ
(Bolu Abant İzzet Baysal Üniversitesi, Tıp Fakültesi, Nöroloji Anabilim Dalı, Bolu, Türkiye)
Yıl: 2021Cilt: 4Sayı: 3ISSN: 2618-6454 / 2618-6454Sayfa Aralığı: 230 - 236İngilizce

26 0
Relationship between intracellular pathogens Toxoplasma gondii and Borrelia burgdorferi infections and migraine
Aim: In this study, the serological values of our patients followed up with a diagnosis of migraine were compared with the results of healthy controls in terms of possible association with intracellular pathogens, Toxoplasma gondii and Borrelia burgdorferi. Methods: Fifty patients with migraine, randomly selected among migraine patients without any additional disease, who applied to Bolu Abant Izzet Baysal Training and Research Hospital between January 1, 2015 and August 31, 2019 were included in the study. Fifty subjects without headache were included as control group. The history of infectious diseases of the patient and control groups (Toxoplasma gondii, Borrelia burgdorferi- causing Lyme disease) was determined by serological diagnostic methods. Results: The study group consisted of 64 women with a mean age of 45.5±13.1 (15-76) years. Migraine and control groups were found to be similar in terms of age (p=0.059) and gender (p=0.211) distributions. The frequency of Toxoplasma gondii positivity in the migraine group was 28% (n=14) and 10% (n=5) in the control group. The frequency of Lyme was 19.6% (n=11) in the migraine group and 14.3% (n=8) in the control group. The frequency of Toxoplasma gondii positivity was statistically significantly higher in the migraine group (p=0.022), while the frequency of Lyme was found to be similar in the migraine and control groups (p=0.450). Conclusion: The results of our study suggest that there are statistically significant differences between migraine and control groups only in terms of Toxoplasma gondii positivity rates, not Lyme. However, we believe that larger sample studies are needed to determine the detailed relationship between migraine and Toxoplasma gondii infection.
DergiAraştırma MakalesiErişime Açık
  • [1]Stovner L, Hagen K, Jensen R, et al. The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia. 2007; 27(3):193- 210.
  • [2]Society HCCOTIH. The international classification of headache disorders, (beta version). Cephalalgia. 2013; 33(9):629-808.
  • [3]Schoonman GG, Schytz HW, Ashina M. Migraine trigger factors. Oxford Textbook of Headache Syndromes. 2020:67.
  • [4]Ferrigno G, Mazza M, Morelli M, et al. Chronic migraine as unusual presentation of syphilis. Xlvii Congresso Nazionale 22-25 Ottobre 2016 – Venezia.
  • [5]Nayeri T, Sarvi S, Moosazadeh M, Hosseininejad Z, Amouei A, Daryani A. Association between Toxoplasma gondii infection and headache: a systematic review and meta-analysis. Infect Disord Drug Targets. 2020. doi: 10.2174/1871526520666200617135851.
  • [6]Koseoglu E, Yazar S, Koc I. Is Toxoplasma gondii a causal agent in migraine? Am J Med Sci. 2009;338(2):120-22.
  • [7]Feder HM Jr. Lyme disease in children. Infect Dis Clin North Am. 2008;22(2):315-26.
  • [8]Centers for Disease Control and Prevention. Lyme Disease: Diagnosis and Testing. CDC. Available at http://www.cdc.gov/lyme/diagnosistestin g/LabTest/TwoStep/index.html. November 20, 2019; Accessed: March 30, 2021.
  • [9]Flegr J. Neurological and neuropsychiatric consequences of chronic Toxoplasma infection. Curr Clin Micro Rpt. 2015; 2(4):163-72.
  • [10]Abo-Al-Ela HG. Toxoplasmosis and Psychiatric and Neurological Disorders: A Step toward Understanding Parasite Pathogenesis. ACS Chem Neurosci. 2020 Aug 19;11(16):2393-2406.
  • [11]Tedford E, Mcconkey G. Neurophysiological changes induced by chronic Toxoplasma gondii infection. Pathogens. 2017; 6(2):19.
  • [12]Prandota J, Gryglas A, Fuglewicz A, et al. Recurrent headaches may be caused by cerebral toxoplasmosis. World J Clin Pediatr. 2014;3(3):59-68.
  • [13]Akturk HK, Sotello D, Ameri A, et al. Toxoplasma Infection in an Immunocompetent Host: Possible Risk of Living with Multiple Cats. Cureus. 2017;9(3):e1103.
  • [14]Prandota J. Recurrent headache as the main symptom of acquired cerebral toxoplasmosis in nonhuman immunodeficiency virusinfected subjects with no lymphadenopathy: the parasite may be responsible for the neurogenic inflammation postulated as a cause of different types of headaches. Am J Ther. 2007; 14(1):63-105.
  • [15]Alvarado-Esquivel C, Del Rosario RicoAlmochantaf Y, Sanchez-Anguiano LF, et al. Toxoplasma gondii Infection and Headache: A Matched Case-Control Study in a Public Hospital in Durango City, Mexico. J Clin Med Res. 2018; 10(1):27-31.
  • [16]Schlüter D, Däubener W, Schares G, et al. Animals are key to human toxoplasmosis. Int J Med Microbiol. 2014; 304(7):917-29.
  • [17]Mendez OA, Koshy AA. Toxoplasma gondii: Entry, association, and physiological influence on the central nervous system. PLoS Pathog. 2017; 13(7):e1006351.
  • [18]Silva CS, Neves Ede S, Benchimol EI, et al. Postnatal acquired toxoplasmosis patients in an infectious diseases reference center. Braz J Infect Dis. 2008; 12(5):438-41.
  • [19]Kazak E, Helvaci NY, Helvaci S. Nöroborrelyoz. Uludağ Üniversitesi Tıp Fakültesi Dergisi. 2013; 39(2):137-45.
  • [20]Livengood JA, Gilmore RD. Invasion of human neuronal and glial cells by an infectious strain of Borrelia burgdorferi. Microbes Infect. 2006; 8(14-15):2832-40.
  • [21]Grab DJ, Nyarko E, Nikolskaia OV, et al. Human brain microvascular endothelial cell traversal by Borrelia burgdorferi requires calcium signaling. Clin Microbiol Infect. 2009; 15(5):422-26.
  • [22]Cepok S, Zhou D, Vogel F, et al. The Immune Response at Onset and During Recovery From Borrelia burgdorferi Meningoradiculitis. Arch Neurol. 2003; 60(6):849-55.
  • [23]Rupprecht TA, Plate A, Adam M, et al. The chemokine CXCL13 is a key regulator of B cell recruitment to the cerebrospinal fluid in acute Lyme neuroborreliosis. J Neuroinflammation. 2009;6:42.
  • [24]Pachner A, Amemiya K, Delaney E, et al. Interleukin-6 is expressed at high levels in the CNS in Lyme neuroborreliosis. Neurology. 1997; 49(1):147-52.
  • [25]Rauer S, Kastenbauer S, Fingerle V, et al. Lyme neuroborreliosis. Deutsches Ärzteblatt International. 2018; 115(45):751.
  • [26]Marques AR. Lyme neuroborreliosis. CONTINUUM: Lifelong Learning in Neurology. 2015; 21(6):1729-44.
  • [27]Kowacs PA, Martins RT, Piovesan EJ, et al. Chronic unremitting headache associated with Lyme disease-like illness. Arq Neuropsiquiatr. 2013;71(7):470-73.
  • [28]Scelsa SN, Lipton RB, Sander H, Herskovitz S. Headache characteristics in hospitalized patients with Lyme disease. Headache. 1995;35(3):125-30.
  • [29]Brinck T, Hansen K, Olesen J. Headache resembling tension-type headache as the single manifestation of Lyme neuroborreliosis. Cephalalgia. 1993; 13(3):207-9.
  • [30]Moses JM, Riseberg RS, Mansbach JM. Lyme disease presenting with persistent headache. Pediatrics. 2003; 112(6):e477-e9.

TÜBİTAK ULAKBİM Ulusal Akademik Ağ ve Bilgi Merkezi Cahit Arf Bilgi Merkezi © 2019 Tüm Hakları Saklıdır.